Theme IIb – Predictive Toxicology – Recent Advances in Specific Assessments

Coordinators

Nathalie Alépée, L’Oréal, Aulnay-sous-Bois, France
Rodger Curren, IIVS, Gaithersburg, MD, USA

  1. Exposure
    Robert Landsiedel, BASF, Germany
    John Wambaugh, EPA, USA
  2. Topical toxicity
    Nathalie Alépée, L’Oreal, France
    Helena Kandárová, SETOX/MatTek
  3. Repeated dose toxicity
    Michael Schwarz, University of Tübingen, Germany
    Gladys Ouédraogo, L’Oreal, France
  4. Skin sensitization
    Gavin Maxwell, Unilever, UK
    Tzutzuy Ramirez, BASF, Germany
  5. Endocrine disruption
    David Dix, EPA, USA
    Derek Knight, ECHA, Finland
  6. Reproductive & developmental toxicology
    George Daston, Procter& Gamble, USA
    Koichi Saito, Sumitomo Chemical Co., Japan
  7. Genotoxicity/Carcinogenicity
    David Kirkland, Kirkland Consulting, UK
    Rolf Fautz, KAO Europe, Germany
  8. Inhalation toxicity
    Michaela Aufderheide, Cultex, Germany
    Samuel Constant, Epithelix, Switzerland
  9. Ecotoxicology
    Scott Belanger, Procter & Gamble, USA
    Stefan Scholz, UFZ, Germany